Olanzapine increases cell mitotic activity and oligodendrocyte-lineage cells in the hypothalamus

Neurochemistry International

Volumn 57, Issue 5, 2010, Pages 565-571

  Yamauchi, Takahira ^a   Tatsumi, Kouko ^a   Makinodan, Manabu ^a   Kimoto, Sohei ^a   Toritsuka, Michihiro ^a   Okuda, Hiroaki ^a   Kishimoto, Toshifumi ^a   Wanaka, Akio ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antipsychotic drug; Cell proliferation; Oligodendrocyte; Weight gain

Indexed keywords

BROXURIDINE; GHRELIN; HALOPERIDOL; INSULIN; LEPTIN; OLANZAPINE; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; FEMALE; FOOD INTAKE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; MITOSIS; MOUSE; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; VOLUNTARY MOVEMENT; WEIGHT GAIN;

ADIPOCYTES; ANIMALS; ANTIMETABOLITES; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIOLOGICAL MARKERS; BODY TEMPERATURE; BODY WEIGHT; BROMODEOXYURIDINE; CELL LINEAGE; CELL PROLIFERATION; CELL SIZE; EATING; ENERGY METABOLISM; FEMALE; HALOPERIDOL; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MITOSIS; MOTOR ACTIVITY; OLIGODENDROGLIA;

MUS;

EID: 77956232455     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.07.003     Document Type: Article

References (31)

1. Allison D., Mentore J., Heo M., Chandler L., Cappelleri J., Infante M., Weiden P. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am. J. Psychiatry 1999, 156:1686-1696.
2. Baptista T., Zarate J., Joober R., Colasante C., Beaulieu S., Paez X., Hernandez L. Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics. Curr. Drug Targets 2004, 5:279-299.
3. Byne W., Kidkardnee S., Tatusov A., Yiannoulos G., Buchsbaum M.S., Haroutunian V. Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophr. Res. 2006, 85:245-253.
4. Consensus Statement Consensus development conference on antipsychotic drugs and obesity. Obes. Res. 2004, 12:362-368.
5. Cooper G.D., Pickavance L.C., Wilding J.P., Halford J.C., Goudie A.J. A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology (Berl.) 2005, 181:80-89.
6. Cope M.B., Nagy T.R., Fernández J.R., Geary N., Casey D.E., Allison D.B. Antipsychotic drug-induced weight gain: development of an animal model. Int. J. Obes. (Lond.) 2005, 29:607-614.
7. Doetsch F., Garcia-Verdugo J.M., Alvarez-Buylla A. Regeneration of a germinal layer in the adult mammalian brain. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:11619-11624.
8. Eder U., Mangweth B., Ebenbichler C., Weiss E., Hofer A., Hummer M., Kemmler G., Lechleitner M., Fleischhacker W.W. Association of olanzapine-induced weight gain with an increase in body fat. Am. J. Psychiatry 2001, 158:1719-1722.
9. Fountaine R.J., Taylor A.E., Mancuso J.P., Greenway F.L., Byerley L.O., Smith S.R., Most M.M., Fryburg D.A. Increased food intake and energy expenditure following administration of olanzapine to healthy men. Obesity 2010, Epub ahead. 10.1038/oby.2010.6.
10. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
11. Graham K.A., Perkins D.O., Edwards L.J., Barrier R.C., Lieberman J.A., Harp J.B. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis. Am. J. Psychiatry 2005, 162:118-123.
12. Green A., Patel J., Goisman R., Allison D., Blackburn G. Weight gain from novel antipsychotic drugs: need for action. Gen. Hosp. Psychiatry 2000, 22:224-235.
13. Hedenmalm K., Hägg S., Ståhl M., Mortimer O., Spigset O. Glucose intolerance with atypical antipsychotics. Drug Saf. 2002, 25:1107-1116.
14. Hof P.R., Haroutunian V., Copland C., Davis K.L., Buxbaum J.D. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem. Res. 2002, 27:1193-1200.
15. Hof P.R., Haroutunian V., Friedrich V.L., Byne W., Buitron C., Perl D.P., Davis K.L. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry. 2003, 53:1075-1085.
16. Kodama M., Fujioka T., Duman R.S. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol. Psychiatry 2004, 56:570-580.
17. Kokoeva M.V., Yin H., Flier J.S. Neurogenesis in the hypothalamus of adult mice: potential role in energy balance. Science 2005, 310:679-683.
18. Leucht S., Corves C., Arbter D., Engel R.R., Li C., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373:31-41.
19. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., Hsiao J.K. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 2005, 353:1209-1223.
20. Magavi S.S., Leavitt B.R., Macklis J.D. Induction of neurogenesis in the neocortex of adult mice. Nature 2000, 405:951-955.
21. Masuo Y., Matsumoto Y., Morita S., Noguchi J. A novel methods for counting spontaneous motor activity in tha rat. Brain. Res. Brain Res. Protoc. 1997, 1:321-326.
22. Minet-Ringuet J., Even P.C., Valet P., Carpéné C., Visentin V., Prévot D., Daviaud D., Quignard-Boulange A., Tomé D., de Beaurepaire R. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment. Mol. Psychiatry 2007, 12:562-571.
23. Oriot P., Feys J.L., Mertens de Wilmars S., Misson A., Ayache L., Fagnart O., Gruson D., Luts A., Jamart J., Hermans M.P., Buysschaert M. Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study. Diabetes Metab. 2008, 34:490-496.
24. Pencea V., Bingaman K.D., Wiegand S.J., Luskin M.B. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum thalamus, and hypothalamus. J. Neurosci. 2001, 21:6706-6717.
25. Sharma T., Hughes C., Soni W., Kumari V. Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia. Psychopharmacology (Berl.) 2003, 169:398-403.
26. Shen P.J., Larm J.A., Gundlach A.L. Expression and plasticity of galanin systems in cortical neurons, oligodendrocyte progenitors and proliferative zones in normal brain and after spreading depression. Eur. J. Neurosci. 2003, 18:1362-1376.
27. Tatsumi K., Takebayashi H., Manabe T., Tanaka K.F., Makinodan M., Yamauchi T., Makinodan E., Matsuyoshi H., Okuda H., Ikenaka K., Wanaka A. Genetic fate mapping of Olig2 progenitors in the injured adult cerebral cortex reveals preferential differentiation into astrocytes. J. Neurosci. Res. 2008, 86:3494-3502.
28. Tang C., Akabayashi A., Manitiu A., Leibowitz S.F. Hypothalamic galanin gene expression and peptide levels in relation to circulating insulin: possible role in energy balance. Neuroendocrinology 1997, 65:265-275.
29. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., Starkey M., Webster M.J., Yolken R.H., Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
30. Wirshing D.A. Adverse effects of atypical antipsychotics. J. Clin. Psychiatry 2001, 62(Suppl. 21):7-10.
31. Wexler B.E., Zhu H., Bell M.D., Nicholls S.S., Fulbright R.K., Gore J.C., Colibazzi T., Amat J., Bansal R., Peterson B.S. Neuropsychological near normality and brain structure abnormality in schizophrenia. Am. J. Psychiatry. 2009, 166:189-195.